Retroviral protease inhibitors
US5648364A · kind A · utility
8Cited by
13References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 1995 |
| Grant date | Jul 15, 1997 |
| Priority date | — |
| Expiry date | Mar 21, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.